List of works - Marte Lie Høivik

Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation

scientific article published on 16 March 2016

Anaemia in inflammatory bowel disease: a population-based 10-year follow-up

scientific article published on 31 October 2013

Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis

scientific article

Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).

scientific article published on 13 October 2011

Does the Introduction of Biosimilars Change Our Understanding about Treatment Modalities for Inflammatory Bowel Disease?

scientific article published in February 2017

Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study.

scientific article

Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients

article

Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease

scientific article

Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study

scientific article

Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis

scientific article

Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study

scientific article published on 20 September 2011

Irritable bowel-like symptoms in ulcerative colitis are as common in patients in deep remission as with inflammation; results from a population-based study (the IBSEN study).

scientific article published on 27 November 2017

Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study

scientific article published on May 2017

Malignancies in patients with inflammatory bowel disease: Results from 20 years of follow-up in the IBSEN study

scientific article published on 31 October 2016

Mortality and Causes of Death in Ulcerative Colitis: Results from 20 Years of Follow-up in the IBSEN Study

scientific article published on 9 September 2015

Need for standardization in population-based quality of life studies: a review of the current literature

scientific article published on March 2010

Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study

scientific article

Patients' perceptions of quality of care and follow-up in inflammatory bowel disease

scientific article published on 4 December 2015

Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies

scientific article

Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease

scientific article published on 21 June 2016

Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study).

scientific article published on 3 July 2015

Switching from Remicade® to Remsima® is well Tolerated and Feasible: A Prospective, Open-label Study

scientific article published on 22 September 2016

The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of Life

scientific article

The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls

scientific article

Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population

scientific article published on 7 September 2016

What have we learnt about the role of the environment and natural course of IBD in the new millennium? 20-year follow-up of the IBSEN cohort

scientific article published on 17 December 2014

Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study

scientific article published on 20 June 2012

List of works by Marte Lie Høivik

Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation

Anaemia in inflammatory bowel disease: a population-based 10-year follow-up

Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis

Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).

Does the Introduction of Biosimilars Change Our Understanding about Treatment Modalities for Inflammatory Bowel Disease?

Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study.

Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients

Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease

Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study

Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis

Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study

Irritable bowel-like symptoms in ulcerative colitis are as common in patients in deep remission as with inflammation; results from a population-based study (the IBSEN study).

Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study

Malignancies in patients with inflammatory bowel disease: Results from 20 years of follow-up in the IBSEN study

Mortality and Causes of Death in Ulcerative Colitis: Results from 20 Years of Follow-up in the IBSEN Study

Need for standardization in population-based quality of life studies: a review of the current literature

Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study

Patients' perceptions of quality of care and follow-up in inflammatory bowel disease

Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies

Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease

Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study).

Switching from Remicade® to Remsima® is well Tolerated and Feasible: A Prospective, Open-label Study

The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of Life

The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls

Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population

What have we learnt about the role of the environment and natural course of IBD in the new millennium? 20-year follow-up of the IBSEN cohort

Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study